BlueBlood Ventures Limited

BSE:539637 Stock Report

Market Cap: ₹33.2m

BlueBlood Ventures Past Earnings Performance

Past criteria checks 3/6

BlueBlood Ventures's earnings have been declining at an average annual rate of -8%, while the Capital Markets industry saw earnings growing at 20% annually. Revenues have been declining at an average rate of 87.1% per year. BlueBlood Ventures's return on equity is 7%, and it has net margins of 66.1%.

Key information

-8.0%

Earnings growth rate

-8.1%

EPS growth rate

Capital Markets Industry Growth20.7%
Revenue growth rate-87.1%
Return on equity7.0%
Net Margin66.1%
Last Earnings Update30 Sep 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How BlueBlood Ventures makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:539637 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 223220
30 Jun 225120
31 Mar 227020
31 Dec 217-210
30 Sep 217-400
30 Jun 216-510
31 Mar 215-710
31 Dec 2013-1110
30 Sep 2022-1510
30 Jun 2022-2210
31 Mar 2021-2820
31 Dec 1913-2430
30 Sep 196-1930
30 Jun 197-1030
31 Mar 197-230
31 Dec 187-240
30 Sep 186-240
30 Jun 18302140
31 Mar 18598350
31 Dec 17602330
30 Sep 17606420
30 Jun 17317330
31 Mar 1727240
31 Mar 167110
31 Mar 1531110
31 Mar 1416010
31 Mar 137110

Quality Earnings: 539637 has high quality earnings.

Growing Profit Margin: 539637 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 539637 has become profitable over the past 5 years, growing earnings by -8% per year.

Accelerating Growth: 539637 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 539637 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Capital Markets industry (20.4%).


Return on Equity

High ROE: 539637's Return on Equity (7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/08/26 10:33
End of Day Share Price 2023/05/29 00:00
Earnings2022/09/30
Annual Earnings2022/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BlueBlood Ventures Limited is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution